German MPN-Registry for BCR-ABL 1-Negative Myeloid Neoplasms (Study Group Ulm)
ConditionBCR-ABL1-Negative Myeloid Neoplasms
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUniversity of Ulm
About this trial
To register a large number of patients with the diagnosis of a BCR-ABL 1- negative myeloid neoplasm (according to WHO 2008 / 2016 classification) in participating centers
To store samples from all patients (e.g. bone marrow aspirate, peripheral blood, plasma, and buccal swap, skin biopsy samples in exceptional cases)
To perform morphologic and genetic analyses
To assess clinical characteristics and outcome data using a defined catalogue containing clinically relevant variables
To assess biological disease features and correlate with clinical outcome data (prognostic and predictive markers)
To assess quality of life
Eligibility criteria
Qualifiers
Patients with BCR-ABL 1-myeloid neoplasia according to WHO classification or IWG MRI criteria
Age ≥ 18 years. There is no upper age limit.
Signed written informed consent.
Disqualifiers
Severe neurological or psychiatric disorder interfering with ability to give an informed consent
No consent for registration, storage and handling of the personal data
Trial design
Treatments tested in this trial
- Registry study
Treatment groups
No treatment groups listed
Sponsors and collaborators
Source ClinicalTrials.gov